Flagship co-founded Ensemble Discovery in 2003 together with Professor David Liu of Harvard University. The company is based on technology invented by Professor Liu known as DNA-programmed chemistry, a revolutionary approach to controlling chemical synthesis that enables discovery of chemical compounds and chemical reactions on an unprecedented scale. Having assembled a world class team, Ensemble is currently pursuing applications in drug discovery, biologic detection, and other specialty chemical and material markets. Flagship Managing Partner Noubar Afeyan is Chairman, and General Partner Doug Cole is a Director.

www.ensemblediscovery.com